DNOW Faces Lawsuit After Stock Plummets 19.1% on Poor Earnings

Edgen Stock·Mar 22 2026, 20:07

Share to

Share to

Copy link

Key Takeaways

DNOW Inc. is facing a securities fraud investigation from the Rosen Law Firm, creating significant legal and financial risk for the company. The probe was initiated after the company's stock value collapsed following the release of a disappointing quarterly earnings report that missed Wall Street estimates.

DNOW stock fell 19.1% on February 20, 2026, after the company reported weak fourth-quarter 2025 financial results.
The poor earnings report included a significant, undisclosed loss and failed to meet analyst expectations, triggering the sharp sell-off.
The Rosen Law Firm is now preparing a class-action lawsuit to recover losses for investors who purchased DNOW securities.

DNOW Stock Tumbles 19.1% After Disappointing Q4 Results

DNOW Inc. (NYSE: DNOW) shares declined 19.1% on February 20, 2026, after the company disclosed disappointing financial results for the fourth quarter of 2025. The report, which revealed a significant loss and missed Wall Street's expectations, triggered a sharp drop in investor confidence and erased a substantial portion of the company's market capitalization in a single day.

The negative financial performance serves as the foundation for subsequent legal challenges. The sharp market reaction indicates that investors were caught off guard by the extent of the company's underperformance, raising questions about the company's prior business disclosures to the public.

Rosen Law Firm Prepares Class-Action Lawsuit

Following the stock's collapse, the Rosen Law Firm, a global investor rights firm, announced on March 22, 2026, that it is continuing its investigation into potential securities claims against DNOW. The firm alleges that DNOW may have issued "materially misleading business information" to the investing public, leading to shareholder losses.

The investigation is a precursor to a class-action lawsuit being prepared by Rosen Law to recover damages for affected investors. Shareholders who purchased DNOW securities may be eligible for compensation through a contingency fee arrangement, signaling a growing legal risk for the company as it navigates the fallout from its Q4 2025 performance.